Results(4541)
A multicentre, non-interventional, cohort analysis describing the patients’ experience focusing on safety events among metastatic hormone-sensitive prostate cancer patients treated with Androgen Receptor Pathway Inhibitors (ARPIs) followed through a Telemonitoring tool funded by the French national healthcare insurance complemented with a chart review (ESPERANTO)
France
EU PAS number:
EUPAS1000000759
First published:
19/12/2025
Study
Ongoing
Enzalutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) in Metastatic Hormone Sensitive Prostate Cancer (mHSPC): A Non-Interventional Center-based Chart Review in Europe (ENHANCE)
France
Germany
EU PAS number:
EUPAS1000000776
First published:
19/12/2025
Study
Ongoing
NONINTERVENTIONAL CLINICAL STUDY TO CONFIRM ORIGINAL SOURCES AND VERIFY SOURCE DATA FOR UNTREATED PATIENT DATA COMPILED FROM TK2D PUBLICATIONS
United Kingdom
EU PAS number:
EUPAS1000000885
First published:
19/12/2025
Study
Ongoing
DARWIN EU® - Time to onset of thromboembolic events in adults with selected types of cancer
Belgium
Denmark
Estonia
Finland
Germany
Netherlands
Spain
United Kingdom
EU PAS number:
EUPAS1000000814
First published:
19/12/2025
Study
Ongoing
Effectiveness of ABRYSVO® maternal respiratory syncytial virus (RSV) vaccine against RSV in infants in Western Pennsylvania (CASSATT)
United States
EU PAS number:
EUPAS1000000389
First published:
19/12/2025
Study
Planned
Impact of SGLT2i on Rates of Heart Failure Hospitalizations in France: an Interrupted Times Series
France
EU PAS number:
EUPAS1000000723
First published:
19/12/2025
Study
Ongoing
A Study to Evaluate the Vaccine Effectiveness of Abrysvo® for Preventing RSV Hospitalizations in Adults Aged 60 Years or Above (Complementary Study to DAN-RSV)
Denmark
EU PAS number:
EUPAS1000000480
First published:
19/12/2025
Study
Ongoing
Observatoire français de la sclérose en plaques (French MS Registry) - OFSEP
France
First published:
19/12/2025
Network
Clinical Pharmacology Department, Hospital La Paz, School of Medicine
Spain
First published:
19/12/2025
Institution
Educational Institution
Hospital/Clinic/Other health care facility
ENCePP partner
MSBase Foundation Limited
Australia
First published:
19/12/2025
Institution
Not-for-profit
ENCePP partner
The Saving Kids With Cancer Foundation (SKCF)
Poland
First published:
19/12/2025
Institution
Not-for-profit
Patient organisation/association
The PHARMO Institute for Drug Outcomes Research (PHARMO Institute)
Netherlands
First published:
19/12/2025
Institution
Non-Pharmaceutical company
ENCePP partner
Pharmacovigilance Program from Laboratory Signals at La Paz University Hospital
First published:
19/12/2025
Spain
Data source
Human
Hospital inpatient records
Cystic Fibrosis Registry of Ireland
First published:
19/12/2025
Ireland
Data source
Human
Disease registry
International Severe Asthma Registry
First published:
19/12/2025
Argentina
Australia
Belgium
Brazil
Bulgaria
Canada
Colombia
Denmark
Ecuador
Estonia
Germany
Greece
Hungary
India
Ireland
Italy
Japan
Korea, Republic of
Kuwait
Mexico
Netherlands
Norway
Poland
Portugal
Saudi Arabia
Singapore
Spain
Taiwan
United Arab Emirates
United Kingdom
United States
Data source
Human
Disease registry
Casiopea Plus
First published:
19/12/2025
Colombia
Spain
Data source
Human
Administrative healthcare records (e.g., claims)
Hospital discharge records
Hospital inpatient records
Pharmacy dispensing records
Registration with healthcare system
Specialist ambulatory care records
Danish registries (access/analysis)
First published:
19/12/2025
Denmark
Data source
Human
Administrative healthcare records (e.g., claims)
Biobank
Birth registry
Cancer registry
Death registry
Disease registry
Drug registry
Hospital discharge records
Other
Pharmacy dispensing records
Population registry
Registration with healthcare system
Specialist ambulatory care records
Vaccination registry
Registro Italiano Sclerosi Multipla e Patologie Correlate (Italian Multiple Sclerosis and Related Disorders Register)
First published:
19/12/2025
Italy
Data source
Human
Disease registry
PHARMO Data Network
First published:
19/12/2025
Netherlands
Data source
Human
Administrative healthcare records (e.g., claims)
Birth registry
Cancer registry
Death registry
Hospital discharge records
Hospital inpatient records
Hospital outpatient visit records
Other
Pharmacy dispensing records
Primary care medical records
Specific Use-result Surveillance of Spiriva Respimat in asthmatics (patients with mild to moderate persistent asthma)
Japan
EU PAS number:
EUPAS19173
First published:
19/12/2025
Study
Finalised
Initiation of Sodium-Glucose Cotransporter 2 inhibitors after first hospitalization for heart failure: a population-based cohort study
France
EU PAS number:
EUPAS1000000378
First published:
19/12/2025
Study
Finalised
CABOLIFE: A Prospective Non-Interventional Study on Effectiveness and Safety of Cabozantinib in Real-Life Setting for Previously Treated Patients with Neuroendocrine Tumours
Austria
Germany
EU PAS number:
EUPAS1000000752
First published:
19/12/2025
Study
Planned
Impact of biologics on inhaled corticosteroids reduction (MOON LIGHT)
Argentina
Belgium
Brazil
Bulgaria
Canada
Colombia
Denmark
Estonia
France
Greece
India
Ireland
Italy
Japan
Korea, Republic of
Kuwait
Mexico
Norway
Poland
Portugal
Saudi Arabia
Singapore
Spain
Taiwan
United Arab Emirates
United Kingdom
United States
EU PAS number:
EUPAS1000000855
First published:
19/12/2025
Study
Ongoing
Periodic Knowledge, Attitudes, and Behavior (KAB) Survey of Certified Prescribers to Assess Understanding of the Risks with the BKEMV™ Risk Evaluation and Mitigation Strategy (REMS) (20240216)
United States
EU PAS number:
EUPAS1000000367
First published:
19/12/2025
Study
Ongoing
Real-world Comparative Effectiveness of Anti-EGFRs with Doublet Chemotherapy Versus Doublet Chemotherapy with or without Bevacizumab in Firstline Among RAS/RAF Wild-type, non-dMMR/MSI High mCRC Patients with Left-sided Primary Tumors in the Flatiron Health CRC Enhanced Datamart (20240215)
United States
EU PAS number:
EUPAS1000000470
First published:
19/12/2025
Study
Discontinued
DARWIN EU® - Alzheimer’s Disease: Incidence, Prevalence, and Individuals' Characteristics
Croatia
Denmark
Germany
Netherlands
United Kingdom
EU PAS number:
EUPAS1000000826
First published:
18/12/2025
Study
Ongoing
DARWIN EU® - Encephalitis risk in pediatric varicella vaccine recipients
Denmark
Finland
Norway
Spain
EU PAS number:
EUPAS1000000813
First published:
18/12/2025
Study
Ongoing
Safety of IBD drugs during pregnancy and breasfeeding: mothers and babies’ outcomes (DUMBO 2 registry)
Spain
EU PAS number:
EUPAS1000000887
First published:
18/12/2025
Study
Finalised
Rivaroxaban real world effectiveness in patients with atrial fibrillation (GUARDIAN)
Bosnia and Herzegovina
Serbia
EU PAS number:
EUPAS1000000869
First published:
18/12/2025
Study
Finalised
Survey among healthcare professionals (neurologists treating patients with MS along with MS specialist nurses) and patients in selected European countries plus Canada to evaluate the knowledge required for the safe use of Mayzent (siponimod)
Canada
Croatia
Denmark
Germany
Netherlands
Spain
Sweden
EU PAS number:
EUPAS44782
First published:
18/12/2025
Study
Finalised
International Severe Asthma Registry (ISAR)
Argentina
Australia
Belgium
Brazil
Bulgaria
Canada
Colombia
Denmark
Ecuador
Estonia
Germany
Greece
Hungary
India
Ireland
Italy
Japan
Korea, Republic of
Kuwait
Mexico
Netherlands
Norway
Poland
Portugal
Saudi Arabia
Singapore
Spain
Taiwan
United Arab Emirates
United Kingdom
United States
EU PAS number:
EUPAS23651
First published:
18/12/2025
Study
Finalised
Risk of Safety Events Among Patients with UC and PsA Treated with Tofacitinib and Other Advanced Treatments in the United States
United States
EU PAS number:
EUPAS103443
First published:
18/12/2025
Study
Finalised
Post Marketing Surveillance on Long Term Drug Use of JARDIANCE® Tablets in Patients with chronic heart failure in Japan (PMS of JARDIANCE in CHF)
Japan
EU PAS number:
EUPAS44340
First published:
18/12/2025
Study
Finalised
Pfizer Registry of Outcomes in Growth Hormone RESearch (PROGRES) 2.0: A multi-country non-interventional, observational, prospective cohort study among participants treated with human growth hormone (hGH) treatments Genotropin (somatropin) and Ngenla (somatrogon) under routine clinical care.
Armenia
Belgium
Brazil
Bulgaria
China
Czechia
France
Georgia
Germany
Hong Kong
Italy
Malaysia
Poland
Portugal
Saudi Arabia
Slovenia
Sri Lanka
United Kingdom
United States
EU PAS number:
EUPAS1000000705
First published:
18/12/2025
Study
Ongoing
A regulatory requirement non interventional study to monitor the safety and effectiveness of JARDIANCE DUO® (empagliflozin/metformin, 5/500mg, 5/850mg, 5/1000mg, 12.5/500mg, 12.5/850mg, 12.5/1000mg) in Korean patients with type 2 diabetes mellitus (JARDIANCE DUO® rPMS)
Korea, Republic of
EU PAS number:
EUPAS24004
First published:
18/12/2025
Study
Finalised
A regulatory requirement non interventional study to monitor the safety and effectiveness of JARDIANCE® (empagliflozin 10mg, 25mg) in Korean patients with type 2 diabetes mellitus (JARDIANCE® rPMS in Korean patients with T2DM)
Korea, Republic of
EU PAS number:
EUPAS13627
First published:
18/12/2025
Study
Finalised
Real world glycemic effectiveness of linagliptin (Tradjenta®) among type 2 diabetes mellitus adults by age and renal function.
United States
EU PAS number:
EUPAS21548
First published:
18/12/2025
Study
Finalised
Compare data sources